EUVIMEDEUVIMED entdecken
Crossref

Integrating UPLC‐MS/MS Bioinformatics and In Vivo Experiments Validation to Elucidate the Mechanism of Wenzi Jiedu Decoction in Suppressing Colorectal Cancer

Tianqing Sang iD, Aoshengxiong Liang, Hongli Zhou, Wenli Qiu, Lijing Shi, Hongguang Zhou iD

Phytochemical Analysis · 2025

DOI: 10.1002/pca.3495 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytochemical Analysis, 2025. Verfasst von Tianqing Sang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Traditional Chinese Medicine, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Drugs, Chinese Herbal, Tandem Mass Spectrometry, Computational Biology. Die Arbeit nennt 51 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

We used ultra‐performance liquid chromatography tandem mass spectrometry (UPLC‐MS/MS), bioinformatics, and in vivo experiments to study the anti‐colorectal cancer (CRC) effects of Wenzi Jiedu Decoction (WJD).

Methods

Detected the main components of WJD by UPLC‐MS/MS. Obtained WJD targets and CRC targets through the open source database. Analyzed the WJD‐CRC targets from a macro perspective by PPI, GO, and KEGG analyses. Validated bioinformatics findings by molecular docking and animal experiments.

Results

This study obtained 91 active compounds and 240 targets of WJD. Intersection with CRC genes (GSE32323 388 DEGs, GSE 215510 1253 DEGs), 36 WJD‐CRC common targets were obtained. PPI and enrichment analyses indicated WJD exerted anti‐CRC effects mainly through the chemokine signaling pathway and apoptosis. Quercetin, Luteolin, Kaempferol, Formononetin, Stigmasterol, and Hederagenin were the main compounds of WJD. CXCL8, BCL‐2, BAX, BCL2L1, CASP3, AKT1, and TP53 were the core targets of WJD‐CRC. Bulk molecular docking showed that core WJD compounds had good docking activity with WJD‐CRC targets. Animal experiments had shown the tumor inhibition rate of the WJD group was 36.53%. WJD could regulate the ratio of CD4+, CD8+, and CD4+/CD8+, reduce the expression of CXCL8, and BCL‐2, and increase the expression of BAX.

Conclusions

This study indicated that the potential mechanism of WJD in the prevention and treatment of CRC had the characteristics of the multi‐target, multi‐path, and multi‐system mechanisms, which were mainly related to the regulation of chemokines and the promotion of apoptosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsDrugs, Chinese HerbalTandem Mass SpectrometryComputational BiologyChromatography, High Pressure LiquidAnimalsHumansMolecular Docking SimulationMiceApoptosisLiquid Chromatography-Mass Spectrometry

Stichwörter der Autor:innen

Wenzi Jiedu Decoctionapoptosisbioinformaticschemokinescolorectal cancer

Substanzen

Drugs, Chinese Herbal

Autor:innen und Institutionen

  • Department of Traditional Chinese Medicine, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.
  • Institute of Oncology, the First Clinical Medical College, Jiangsu Collaborative Innovation Center of Traditional Chinese Medicine Prevention and Treatment of Tumor, Nanjing University of Chinese Medicine, Nanjing, Jian…
  • Department of Radiology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
  • Department of Oncology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.

ORCID-Profile: Tianqing Sang, Hongguang Zhou

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Sang, T., Liang, A., Zhou, H., Qiu, W., Shi, L., & Zhou, H. (2025). Integrating UPLC‐MS/MS Bioinformatics and In Vivo Experiments Validation to Elucidate the Mechanism of Wenzi Jiedu Decoction in Suppressing Colorectal Cancer. Phytochemical Analysis. https://doi.org/10.1002/pca.3495

Vancouver

Sang T, Liang A, Zhou H, Qiu W, Shi L, Zhou H. Integrating UPLC‐MS/MS Bioinformatics and In Vivo Experiments Validation to Elucidate the Mechanism of Wenzi Jiedu Decoction in Suppressing Colorectal Cancer. Phytochemical Analysis. 2025. doi:10.1002/pca.3495

BibTeX
@article{Sang2025,
  author = {Sang, Tianqing and Liang, Aoshengxiong and Zhou, Hongli and Qiu, Wenli and Shi, Lijing and Zhou, Hongguang},
  title = {Integrating UPLC‐MS/MS Bioinformatics and In Vivo Experiments Validation to Elucidate the Mechanism of Wenzi Jiedu Decoction in Suppressing Colorectal Cancer},
  journal = {Phytochemical Analysis},
  year = {2025},
  doi = {10.1002/pca.3495}
}
Kostenlos starten →